Navigation Links
TargetScan Targeted Prostate Biopsy System

ProductsTargetScan Targeted Prostate Biopsy System
Company Envisioneering Medical Technology
Item TargetScan Targeted Prostate Biopsy System
Features The TargetScan System compenentry includes:
  • patented endorectal probe with multiplane mechanical transducer with 3D solid volume imaging capability
  • PC based digital hardware incorporating proprietary software platform for comprehensive imaging, planning, targeting and data storage/retrieval
  • targetscdan controller, with an Image Plane Visualization positioner, for fully atumated transducer movement adn precise scanning control
  • Targetscan platform providing stable and fixed probe positioning
  • Targeted biopsy system with single use needle and guide and multi-position probe carriage providing full sagittal and transverse access to the target site

The targeted Biopsy System consists of:

  • A redirecting guide and position assembly
  • Proprietary biopsy planning software
  • Proprietary bendable biopsy needle kit
Description TargetScan(R) is the latest innovation in prostate mapping, biopsy and cancer treatment guidance. Combining 3-D image acquisition with a stationary probe, this new technology helps physicians plan and execute targeted prostate biopsies -- potentially improving patients' cancer treatment outcomes with less-invasive procedures.
Info Envisioneering Medical Technology
Customer Service: (314) 429-7367
Web site: http://www.envisioneeringmedical.com/

Related medicine products :

1. Total Prostate Specific Antigen
2. PSA Screen (Prostate Specific Antigen)
3. EZ-PSA One-Step Prostate Specific Antigen (PSA) Test
4. Coat-A-Count PAP IRMA (Prostate Acid Phosphatase)
5. MT-BT-5001 Prostate Seeding Needle
6. MT-BT-5011 Prostate Seeding Needle
7. MT-BT-5051-25 Prostate Seeding Needle
8. Prostate Stepper Template
9. Prostate Specific Antigen (PSA) - Rapid Test
10. Multi Frequency Prostate Biopsy Transducer UST-670P
11. Multi Frequency Prostate Biopsy Transducer UST-676P
A general purpose instrument for use around the femur and acetabulum.
Delicate side cutting wire cutter with carbide inserts.
The osteotome shafts are manufactured with stainless steel and are available both straight and curved in 1/4" and 1/2" sizes.
... special purpose scintimammography camera. Offeri...the edge of the detector and separate the breast f...and stabilization and stereotactic imaging for bio...era is a dedicated system with breast containment ...
Medicine Products:
(Date:12/3/2008)...., Dec. 3 MedQuist Inc. (Nasdaq: ... Organization (MTSO) in the world, is pleased to a...l legal matters , , Resolution of the DOJ ... the Company received an administrative HIPAA subp...nt of Justice ("DOJ") on December 17, 2004. The su...
(Date:12/3/2008)...aggressive surgeries were free of tumor recurrence... ROCHESTER, Minn., Dec. 3 /PRNewswire-USNewswire/...th low-grade gliomas survived longest when they un...e the entire tumor. If safely removing the entire ...antly longer when surgery was followed by radiatio...
(Date:12/3/2008)... Aurora Health Care,s Women,s Pavi... and Body Solutions Salon and Spa of,New Berlin p...or breast,cancer; pink hair extensions. , ...ons were being sold for,$15 each at the Aurora Wo...,Solutions Salon and Spa in New Berlin. The profit...
(Date:12/3/2008)...PRNewswire/ -- Breast-Specific Gamma Imaging (BSGI...ty than breast MRI in patients with,inconclusive ...iagnosis of,breast cancer, according to findings ...ological Society of North America (RSNA). BSGI is ...djunctive tool to mammography that can identify,l...
Breaking Medicine News(10 mins):Health News:MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits 2Health News:MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits 3Health News:MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits 4Health News:MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits 5Health News:MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits 6Health News:Mayo Clinic Identifies Best Treatments for Long-Term Survival in Brain Tumor Patients 2Health News:Mayo Clinic Identifies Best Treatments for Long-Term Survival in Brain Tumor Patients 3Health News:Molecular Breast Imaging Outperforms MRI for Patients With Inconclusive Results in the Diagnosis of Cancer 2
...udy to be published in the May issue of the Americ...m the Centres for Disease Control and Prevention s... and more Americans are being diagnosed with diabe...se of obesity which plays a major factor in recent...
...opy would make significant improvement in the figh...lication of three basic criteria of dermoscopy giv...pecialist. // This was shown in a study promoted b...several Catalan and Italian Primary Care Centres. ...
...erapy has been found to be effective in reducing c...es. Nearly 1/3rd of patients with chest pain have ...umerous reassurance efforts by cardiologists, they...heir symptom. Particularly, young women seem be mo...
...ystematic review of studies has found that herbals...ne plasters is highly beneficial for treating shot...ms to be equally effective as pain medication and ...e review comprised 10 randomized controlled trials...
Other Medicine News:Health News:Obesity The Major Cause Of The Increase In Newly Diagnosed Diabetes 2Health News:Dermoscopy An Able Tool For The Fight Against Skin Cancer 2Health News:Non-Cardiac Chest Pain Can Be Treated By Hypnotherapy 2Health News:Herbal Preparation Effective For Treating Short Term Low-Back Pain 2
(Date:12/1/2008)... Genaera Corporation (N...jects has begun in study MSI-1436C-102 (Study 102)...odusquemine (MSI-1436) in overweight and obese typ... the treatment of type 2 diabetes and obesity whic...ulin and leptin pathways through the highly select...
(Date:12/1/2008)...irstCall/ -- GeoVax Labs, Inc.,(OTC Bulletin Boar...eveloping,human vaccines for diseases caused by H...ectious agents, announced today that the launch of...e in twelve sites across North and South America.,...The National Institutes of,Health (NIH), and the ...
(Date:11/30/2008)...SNewswire/ -- Abnormalities in auditory and langua...tism spectrum disorder by using magnetoencephalogr...t the annual meeting of the Radiological Society o...can record the tiny magnetic fields associated wit..., Ph.D., vice chair of research in the Department ...
(Date:11/27/2008)...of acute lymphoblastic leukemia relapse cases aris...osis , , MEMPHIS, Tenn., Nov. 27 /PRNewswir... Research Hospital have identified distinctive gen...acute lymphoblastic leukemia (ALL) that cause rela...atments for ALL relapse in children and, ultimatel...
Breaking Medicine Technology:Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 2GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 3Brain Waves Show Sound Processing Abnormalities in Autistic Children 2Brain Waves Show Sound Processing Abnormalities in Autistic Children 3St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Hospitals Could Improve Outcomes for Patients and Save Millions According to Hill Rom 10th Annual Pressure Ulcer Survey 647 1Hospitals Could Improve Outcomes for Patients and Save Millions According to Hill Rom 10th Annual Pressure Ulcer Survey 647 2Hospitals Could Improve Outcomes for Patients and Save Millions According to Hill Rom 10th Annual Pressure Ulcer Survey 647 3Hospitals Could Improve Outcomes for Patients and Save Millions According to Hill Rom 10th Annual Pressure Ulcer Survey 647 4MedQuist Re launches New Improved Web Site 642 1MedQuist Re launches New Improved Web Site 642 2NPS Pharmaceuticals Commences Tender Offer for 3 0 25 Convertible Notes Due 2008 409 1NPS Pharmaceuticals Commences Tender Offer for 3 0 25 Convertible Notes Due 2008 409 2NPS Pharmaceuticals Commences Tender Offer for 3 0 25 Convertible Notes Due 2008 409 3NPS Pharmaceuticals Commences Tender Offer for 3 0 25 Convertible Notes Due 2008 409 4Proteon Therapeutics Completes 2412 Million Financing and Hires CFO 404 1Proteon Therapeutics Completes 2412 Million Financing and Hires CFO 404 2
...egistration Program to Begin Third Quarter 2007, H...l/ -- Kosan,Biosciences Incorporated presented dat...f its lead Hsp90 inhibitor, tanespimycin,(KOS-953)...ing a,high degree of antitumor activity and tolera...reviously progressed following treatment,with mult...
...BUSINESS WIRE)--Jun 4, 2007 - Molecular Insight,Ph... that the,company will present the results of seve... of the Society of Nuclear Medicine (SNM) in,Washi...ra(TM),(Ultratrace (131)I-MIBG), the company,s cli...or the treatment of malignant,neuroendocrine tumor...
Other Medicine Technology:Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing,Promising Antitumor Activity in Multiple Myeloma at ASCO 2Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing,Promising Antitumor Activity in Multiple Myeloma at ASCO 3Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing,Promising Antitumor Activity in Multiple Myeloma at ASCO 4Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing,Promising Antitumor Activity in Multiple Myeloma at ASCO 5Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing,Promising Antitumor Activity in Multiple Myeloma at ASCO 6Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,at Society Of Nuclear Medicine 2007 Annual Meeting 2Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,at Society Of Nuclear Medicine 2007 Annual Meeting 3Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,at Society Of Nuclear Medicine 2007 Annual Meeting 4